Softness in Europe and APMEA
Europe and APMEA markets declined sequentially, with Europe pipeline healthy but conversion weak; APMEA strategy under review.
Wipro · Material risks, their source context, and severity in the latest available quarter.
ConCallIQ research layer
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Risk intelligence
Europe and APMEA markets declined sequentially, with Europe pipeline healthy but conversion weak; APMEA strategy under review.
Large deals signed in Q1 may take several quarters to fully ramp, limiting near-term revenue upside.
E&U vertical declined 6.3% sequentially due to end of large programs; recovery dependent on pipeline conversion.
Some competitors offering large productivity gains to clients via GenAI, potentially pressuring pricing.